MB
MPM BioImpact Portfolio holdings
AUM
$577M
This Quarter Return
+1.02%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$415M
AUM Growth
+$415M
(+10%)
Cap. Flow
+$64.4M
Cap. Flow
% of AUM
15.5%
Top 10 Holdings %
Top 10 Hldgs %
97.86%
Holding
12
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
iTeos Therapeutics
ITOS
|
$58.1M |
| 2 |
EPZM
Epizyme, Inc
EPZM
|
$6.24M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 92.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Repare Therapeutics
RPTX
$71.7M
| $73.5M | 17.71% | 2,388,337 | – | – |
|
|
TCRR
2
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $68.5M | 16.5% | 3,370,982 | – | – |
|
|
HARP
3
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $66.2M | 15.96% | 3,898,422 | – | – |
|
|
4
iTeos Therapeutics
ITOS
| $58.1M | 14% | +2,355,557 | New | +$58.1M |
|
|
EPZM
5
DELISTED
Epizyme, Inc
EPZM
| $34.1M | 8.21% | 2,854,737 +523,203 | +22% | +$6.24M |
|
|
TPTX
6
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $27M | 6.5% | 308,686 | – | – |
|
7
ADC Therapeutics
ADCT
$345M
| $17.8M | 4.29% | 539,648 | – | – |
|
|
GTHX
8
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $16.4M | 3.96% | 1,423,794 | – | – |
|
9
Y-mAbs Therapeutics
YMAB
$388M
| $12.9M | 3.12% | 337,291 | – | – |
|
10
Merus
MRUS
$4.98B
| $8.41M | 2.03% | 700,879 | – | – |
|
|
AUTL
11
Autolus Therapeutics
AUTL
$399M
| $463K | 0.11% | 39,740 | – | – |
|